Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07545473 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Hyperspectral retinal imaging is a non-invasive imaging modality in which a series of images of the retina are captured using light of different wavelengths. The resulting "hypercube" of data provides a wealth of information about the retinal structure. Our group has developed evidence supporting a role for this technology in the detection of retinal amyloid beta in Alzheimer's disease. We are undertaking further studies to establish the role of this method in the assessment of people with dementia, or those at risk of Alzheimer's disease. In addition, we wish to test whether the approach may have value in other forms of dementia or neurodegenerative disease such as Parkinson's disease, Lewy-Body dementia or vascular dementia.
Trial Details
NCT Number NCT07545473
Lead Sponsor Center for Eye Research Australia
Conditions
(from sponsor)		 Dementia, Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease, Frontotemporal Dementia, Vascular Dementia, Lewy Body Disease, Niemann-Pick Diseases
Related terms Alzheimer Disease, Dementia, Dementia, Vascular, Frontotemporal Dementia, Lewy Body Disease, Neurodegenerative Diseases, Niemann-Pick Diseases, Parkinson Disease
Enrollment 930 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov